1. Outcome of aspirin treatment of antiphospholipid antibody-positive patients

   • Kathleen M. O’Neil

   Clinical Trials Report 04 February 2009 Pages: 1 - 2

2. The use of opioids in the treatment of osteoarthritis: When, why, and how?

   • Jeremy L. R. Goodwin
   • Jan J. Kraemer
   • Zahid H. Bajwa

   OriginalPaper 04 February 2009 Pages: 5 - 14

3. The biomechanics of osteoarthritis: Implications for therapy

   • Joel A. Block
   • Najia Shakoor

   OriginalPaper 04 February 2009 Pages: 15 - 22

4. WNT signaling in osteoarthritis and osteoporosis: What is the biological significance for the clinician?

   • Liesbet Lodewyckx
   • Rik J. U. Lories

   OriginalPaper 04 February 2009 Pages: 23 - 30

5. Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs

   • Matthias Hermann

   OriginalPaper 04 February 2009 Pages: 31 - 35

6. Aspirin and acetaminophen: Should they be available over the counter?

   • Kay Brune
   • Burkhard Hinz
   • Ivan Otterness

   OriginalPaper 04 February 2009 Pages: 36 - 40

7. Antiphospholipid antibodies in rheumatoid arthritis: Identifying the dominoes

   • Debbie A. Gladd
   • Ewa Olech

   OriginalPaper 04 February 2009 Pages: 43 - 51

8. Renal manifestations of the antiphospholipid syndrome

   • David D’Cruz

   OriginalPaper 04 February 2009 Pages: 52 - 60

9. Atherosclerosis in autoimmune diseases

   • Eiji Matsuura
   • Kazuko Kobayashi
   • Luis R. Lopez

   OriginalPaper 04 February 2009 Pages: 61 - 69

10. Neonatal effects of maternal antiphospholipid syndrome

    • Angela Tincani
    • Chiara Biasini Rebaioli
    • Mario Motta

    OriginalPaper 04 February 2009 Pages: 70 - 76

11. Mechanisms of antiphospholipid-induced thrombosis: Effects on the protein C system

    • Denis Wahl
    • Aurélie Membre
    • Thomas Lecompte

    OriginalPaper 04 February 2009 Pages: 77 - 81